ADVERTISEMENT
More Than 64,000 Bottles of an Antibiotic Recalled
The US Food and Drug Administration (FDA) announced the recall of amoxicillin for oral suspension.
What prompted the Class III recall? West-Ward Pharmaceutical noted the product strength was not listed.
The products, manufactured by Hikma Pharmaceuticals in Jordan, were distributed nationwide.
__________________________________________________________________________________________________________________________________________________________________________
RELATED CONTENT
Amoxicillin Recalled
Asthma Med Recalled
__________________________________________________________________________________________________________________________________________________________________________
Presentation |
Lot |
Expiration |
NDC |
Quantity |
400 mg/5 mL, 100 mL (when reconstituted) |
AS1413A |
November 2018 |
00143-9887-01 |
32,006 bottles |
400 mg/5 mL, 100 mL (when reconstituted) |
AS1414A |
November 2018 |
00143-9887-01 |
32,198 bottles |
In March, the company notified the FDA that a number of presentations of cefotaxime sodium (Claforan) injection were on allocation due to increased demand.
--Stephanie Vaccaro
Reference:
US Food and Drug Administration. FDA Enforcement Report – Week of September 28, 2016. www.fda.gov. Accessed September 29, 2016.